| Literature DB >> 26011473 |
Nina Dupuis1,2, Niccolo Curatolo1, Jean-François Benoist1,3, Stéphane Auvin1,2,4.
Abstract
The ketogenic diet (KD) is an established treatment for refractory epilepsy, including some inflammation-induced epileptic encephalopathies. In a lipopolysaccharide (LPS)-induced fever model in rats, we found that animals given the KD for 14 days showed less fever and lower proinflammatory cytokine levels than control animals. However, KD rats exhibited a decrease in circulating levels of arachidonic acid and long-chain n-3 polyunsaturated fatty acids (PUFAs), suggesting that the anti-inflammatory effect of KD was probably not due to an increase in anti-inflammatory n-3 PUFA derivatives. These properties might be of interest in some conditions such as fever-induced refractory epileptic encephalopathy in school-aged children. Wiley Periodicals, Inc.Entities:
Keywords: Epilepsy; FIRES; IL-1β; Ketogenic diet; Polyunsaturated fatty acids
Mesh:
Substances:
Year: 2015 PMID: 26011473 DOI: 10.1111/epi.13038
Source DB: PubMed Journal: Epilepsia ISSN: 0013-9580 Impact factor: 5.864